Equillium, Inc.Equillium, Inc.Equillium, Inc.

Equillium, Inc.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪30.64 M‬USD
−0.2373USD
‪−13.34 M‬USD
‪36.08 M‬USD
‪17.41 M‬
Beta (1Y)
1.23
Employees (FY)
44.00
Revenue / Employee (1Y)
‪820.09 K‬USD
Net income / Employee (1Y)
‪−303.07 K‬USD

About Equillium, Inc.


CEO
Bruce D. Steel
Headquarters
La Jolla
Founded
2017
FIGI
BBG00LSL8C10
Equillium, Inc. engages in the development of products for severe autoimmune and inflammatory, or immuno-inflammatory, disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March, 2017 and is headquartered in La Jolla, CA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Frequently Asked Questions


The current price of EQ is 0.8648 USD — it has increased by 2.89% in the past 24 hours. Watch Equillium, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Equillium, Inc. stocks are traded under the ticker EQ.
EQ stock has risen by 5.46% compared to the previous week, the month change is a −8.19% fall, over the last year Equillium, Inc. has showed a 18.55% increase.
We've gathered analysts' opinions on Equillium, Inc. future price: according to them, EQ price has a max estimate of 8.00 USD and a min estimate of 5.00 USD. Watch EQ chart and read a more detailed Equillium, Inc. stock forecast: see what analysts think of Equillium, Inc. and suggest that you do with its stocks.
EQ reached its all-time high on Jul 13, 2020 with the price of 27.0500 USD, and its all-time low was 0.4500 USD and was reached on Nov 13, 2023. View more price dynamics on EQ chart.
See other stocks reaching their highest and lowest prices.
EQ stock is 5.82% volatile and has beta coefficient of 1.23. Track Equillium, Inc. stock price on the chart and check out the list of the most volatile stocks — is Equillium, Inc. there?
Today Equillium, Inc. has the market capitalization of ‪30.64 M‬, it has increased by 1.45% over the last week.
Yes, you can track Equillium, Inc. financials in yearly and quarterly reports right on TradingView.
Equillium, Inc. is going to release the next earnings report on Nov 12, 2024. Keep track of upcoming events with our Earnings Calendar.
EQ earnings for the last quarter are 0.01 USD per share, whereas the estimation was −0.15 USD resulting in a 106.67% surprise. The estimated earnings for the next quarter are 0.29 USD per share. See more details about Equillium, Inc. earnings.
Equillium, Inc. revenue for the last quarter amounts to ‪13.85 M‬ USD, despite the estimated figure of ‪6.33 M‬ USD. In the next quarter, revenue is expected to reach ‪21.40 M‬ USD.
EQ net income for the last quarter is ‪468.00 K‬ USD, while the quarter before that showed ‪−2.73 M‬ USD of net income which accounts for 117.12% change. Track more Equillium, Inc. financial stats to get the full picture.
No, EQ doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Oct 7, 2024, the company has 44.00 employees. See our rating of the largest employees — is Equillium, Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Equillium, Inc. EBITDA is ‪−9.58 M‬ USD, and current EBITDA margin is −39.90%. See more stats in Equillium, Inc. financial statements.
Like other stocks, EQ shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Equillium, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Equillium, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Equillium, Inc. stock shows the sell signal. See more of Equillium, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.